EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells

Sachin Patil, Vishnu S. Mishra, Nisha Yadav, Puli Chandramouli Reddy, Bimlesh Lochab

ACS Omega · 16.11.2026

DOI: 10.1021/acsomega.6c10278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 16.11.2026. Verfasst von Sachin Patil und 4 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shiv Nadar University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cabazitaxel (CTX) is an effective chemotherapeutic agent for advanced prostate cancer, but limited aqueous solubility and systemic toxicity motivate alternative delivery strategies. Herein, we developed a folate receptor-targeted nanodiamond-based nanoconjugate (ND-PAMAM-FA-CTX) for selective and controlled drug delivery. Cabazitaxel was first converted to CTX-hemisuccinate and subsequently conjugated to a fourth-generation polyamidoamine (PAMAM) dendrimer along with folic acid (FA), followed by covalent attachment to nanodiamonds (NDs). Comprehensive physicochemical characterization confirmed the successful construction of the nanoconjugate while preserving the structural integrity of the nanodiamond core. The resulting platform exhibited high CTX-loading capacity and a sustained, pH-responsive drug-release profile, with enhanced release under acidic conditions relevant to the tumor microenvironment. The drug-free carrier showed excellent biocompatibility, whereas ND-PAMAM-FA-CTX demonstrated superior anticancer activity against folate receptor (FAR)-overexpressing PC3 prostate cancer cells compared with free CTX and nontargeted controls. Flow cytometry and confocal microscopy revealed significantly enhanced cellular uptake mediated by folate receptor-dependent endocytosis, which was further confirmed through competitive inhibition studies using free folic acid. Moreover, ND-PAMAM-FA-CTX exhibited a low nanomolar IC50 value (∼5 nM) and markedly suppressed PC3 cell migration. Overall, these findings demonstrate that ND-PAMAM-FA-CTX is a promising targeted nanotherapeutic platform that combines selective cellular delivery and controlled drug release with enhanced efficacy, offering potential for future targeted chemotherapy applications.

Förderung

  • Shiv Nadar University

Zitieren

APA

Patil, S., Mishra, V. S., Yadav, N., Reddy, P. C., & Lochab, B. (2026). Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells. ACS Omega. https://doi.org/10.1021/acsomega.6c10278

Vancouver

Patil S, Mishra VS, Yadav N, Reddy PC, Lochab B. Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells. ACS Omega. 2026. doi:10.1021/acsomega.6c10278

BibTeX
@article{Patil2026,
  author = {Patil, Sachin and Mishra, Vishnu S. and Yadav, Nisha and Reddy, Puli Chandramouli and Lochab, Bimlesh},
  title = {Folate-Functionalized PAMAM–Nanodiamond Conjugates for Sustained pH-Dependent Cabazitaxel Release and Enhanced Cytotoxicity in Prostate Cancer Cells},
  journal = {ACS Omega},
  year = {2026},
  doi = {10.1021/acsomega.6c10278}
}
Kostenlos starten →